Hydrogen sulfide: From physiology to pharmacology

Inflammation and Allergy - Drug Targets

Volumn 10, Issue 2, 2011, Pages 77-84

  Fiorucci, Stefano ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Carbon monoxide; Cystathionine synthase or cystathione lyase; Cytoprotection; Gasotransmitters; Hydrogen sulphide; Neuromodulation; Nitric oxide; Nociception; Vasorelaxation

Indexed keywords

CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; CYSTEINE; HYDROGEN SULFIDE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; NEUROMODULATION; NOCICEPTION; PHARMACOLOGY; PHYSIOLOGY; VASODILATATION;

EID: 79952747884     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152811794776277     Document Type: Article

References (35)

1. Wang, R. Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter? FASEB J., 2002, 16(13), 1792-1798.
2. Fiorucci, S.; Distrutti, E.; Cirino, G.; Wallace, J.L. The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver. Gastroenterology, 2006, 131(1), 259-271.
3. Moore, P.K.; Bhatia, M.; Moochhala, S. Hydrogen sulfide: from the smell of the past to the mediator of the future? Trends Pharmacol. Sci., 2003, 24(12), 609-611.
4. Murad, F. Nitric oxide and cyclic GMP in cell signaling and drug development. N. Engl. J. Med., 2006, 355(19), 2003-2011.
5. Ghosh, S.; Gal, J.; Marczin, N. Carbon monoxide: endogenous mediator, potential diagnostic and therapeutic target. Ann. Med., 2010, 42(1), 1-12.
6. Yang, G.; Wu, L.; Jiang, B.; Yang, W.; Qi, J.; Cao, K.; Meng, Q.; Mustafa, A.K.; Mu, W.; Zhang, S.; Snyder, S.H.; Wang, R. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science, 2008, 322(5901), 587-590.
7. Gadalla, M.M.; Snyder, S.H. Hydrogen sulfide as a gasotransmitter. J. Neurochem., 2010, 113(1), 14-26.
8. Renga, B. Hydrogen sulfide generation in mammals: the molecular biology of cystathionine-γ-liase. Inflam. Allergy Drug Targets, 2010, 10(2), 85-91
9. Bucci, M.R.; Cirino, G. Hydrogen sulfide in heart and systemic circulation. Inflam. Allergy Drug Targets, 2010, 10(2), 103-108
10. Cipriani, S.; Mencarelli, A. Hydrogen sulfide in gastrointestinal tract and liver physio-pathology. Inflam. Allergy Drug Targets, 2010, 10(2), 92-102.
11. Grundy, D.; Rong, W. Neurophysiology of Hydrogen sulfide. Inflam. Allergy Drug Targets, 2010, 10(2), 109-117.
12. Distrutti E, Pasqualucci A. Hydrogen sulfide in visceral pain. Inflam. Allergy Drug Targets, 2010, 10(2), 123-1323.
13. Distrutti, E.; Cipriani, S.; Renga, B.; Mencarelli, A.; Migliorati, M.; Cianetti, S.; Fiorucci, S. Hydrogen sulphide induces micro opioid receptor-dependent analgesia in a rodent model of visceral pain. Mol. Pain, 2010, 6, 36.
14. Bhatia M. Hydrogen sulfide in inflammation: friend or foe? Inflam. Allergy Drug Targets, 2010, 10(2).
15. Jiang, B.; Tang, G.; Cao, K.; Wu, L.; Wang, R. Molecular mechanism for H(2)S-induced activation of K(ATP) channels. Antioxid. Redox. Signal., 2010, 12(10), 1167-1178.
16. Johansen, D.; Ytrehus, K.; Baxter, G.F. Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemiareperfusion injury--Evidence for a role of KATP channels. Basic Res. Cardiol., 2006, 101(1), 53-60.
17. Meng, Q.H.; Yang, G.; Yang, W.; Jiang, B.; Wu, L.; Wang, R. Protective effect of hydrogen sulfide on balloon injury-induced neointima hyperplasia in rat carotid arteries. Am. J. Pathol., 2007, 170(4), 1406-1414.
18. Zanardo, R.C.; Brancaleone, V.; Distrutti, E.; Fiorucci, S.; Cirino, G.; Fallace, J.L. Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J., 2006, 20(12), 2118-2120.
19. Fiorucci, S.; Antonelli, E.; Distrutti, E.; Rizzo, G.; Mencarelli, A.; Orlandi, S.; Zanardo, R.; Renga, B.; Di Sante, M.; Morelli, A.; Cirino, G.; Fallace, J.L. Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs. Gastroenterology, 2005, 129(4), 1210-1224.
20. Fiorucci, S. Hydrogen sulfide -based therapies: focus on H2S releasing NSAIDs. Inflam. Allergy Drug Targets, 2010, 10(2),
21. Rossoni, G.; Sparatore, A.; Tazzari, V.; Manfredi, B.; Del Soldato, P.; Berti, F. The hydrogen sulphide-releasing derivative of diclofenac protects against ischaemia-reperfusion injury in the isolated rabbit heart. Br. J. Pharmacol., 2008, 153(1), 100-109.
22. Muzaffar, S.; Jeremy, J.Y.; Sparatore, A.; Del Soldato, P.; Angelini, G.D.; Shukla, N. H2S-donating sildenafil (ACS6) inhibits superoxide formation and gp91phox expression in arterial endothelial cells: role of protein kinases A and G. Br. J. Pharmacol., 2008, 155(7), 984-994.
23. Sparatore, A., Perrino, E.; Tazzari, V.; Giustarini, D.; Rossi, R.; Rossoni, G.; Erdmann, K.; Schröder, H.; Del Soldato, P. Pharmacological profile of a novel H(2)S-releasing aspirin. Free Radic. Biol. Med., 2009, 46(5), 586-592.
24. Fiorucci, S.; Santucci, L.; Distrutti, E. NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon. Dig. Liver. Dis., 2007, 39(12), 1043-1051.
25. Fiorucci, S.; Orlandi, S.; Mencarelli, A.; Caliendo, G.; Santagada, V.; Distrutti, E.; Cantucci, L.; Cirino, G.; Fallace, J.L. Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis. Br. J. Pharmacol., 2007, 150(8), 996-1002.
26. Wallace, J.L.; Caliendo, G.; Santagada, V.; Cirino, G.; Fiorucci, S. Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide-releasing diclofenac derivative in the rat. Gastroenterology, 2007, 132(1), 261-271.
27. Szabó, C. Hydrogen sulphide and its therapeutic potential. Nat. Rev. Drug Discov., 2007, 6(11), 917-935.
28. Li, L.; Bhatia, M.; Zhu, Y.Z.; Zhu, Y.C.; Ramnath, R.D.; Wang, Z.J.; Anuar, F.B.; Whiteman, M.; Salto-Tellez, M.; Moore, P.K. Hydrogen sulfide is a novel mediator of lipopolysaccharideinduced inflammation in the mouse. FASEB J., 2005, 19(9), 1196-1198.
29. Zhang, H.; Hegde, A.; Ng, S.W.; Adhikari, S.; Moochhala, S.M.; Bhatia, M. Hydrogen sulfide up-regulates substance P in polymicrobial sepsis-associated lung. J. Immunol., 2007, 179(6), 4153-4160.
30. Lee, A.T.; Shah, J.J.; Li, L.; Cheng, Y.; Moore, P.K.; Khanna, S. A nociceptive-intensity-dependent role for hydrogen sulphide in the formalin model of persistent inflammatory pain. Neuroscience, 2008, 152(1), 89-96.
31. Xu, G.Y.; Winston, J.H.; Shenoy, M.; Zhou, S.; Chen, J.D.; Pasricha, P.J. The endogenous hydrogen sulfide producing enzyme cystathionine-beta synthase contributes to visceral hypersensitivity in a rat model of irritable bowel syndrome. Mol. Pain., 2009, 5, 44.
32. 2S-donating sildenafil (ACS6) inhibits superoxide formation and gp91phox expression in arterial endothelial cells: role of protein kinases A and G. Br. J. Pharmacol., 2008, 155(7), 984-994.
33. Osborne, N.N.; Ji, D.; Abdul Majid, A.S.; Fawcett, R.J.; Sparatore, A.; Del Soldato, P. ACS67, a hydrogen sulfide-releasing derivative of latanoprost acid, attenuates retinal ischemia and oxidative stress to RGC-5 cells in culture. Invest. Ophthalmol. Vis. Sci., 2010, 51(1), 284-294.
34. Perrino, E., Uliva, C.; Lanzi, C.; Del Soldato, P.; Masini, E.; Sparatore, A. New prostaglandin derivative for glaucoma treatment. Bioorg. Med. Chem. Lett., 2009, 19(6), 1639-1642.
35. Lee, M.; Tazzari, V.; Giustarini, D.; Rossi, R.; Sparatore, A.; Del Soldato, P.; McGeer, E.; McGeer, P.L. Effects of hydrogen sulfidereleasing L-DOPA derivatives on glial activation: potential for treating Parkinson disease. J. Biol. Chem,. 2010, 285(23), 17318-17328.